Researcher interests: RNA sensors: novel regulators of gene expression. mRNA structure and function. Translational control of eukaryotic gene expression. Regulation of mRNA splicing and the role of the RNA-activated protein kinase PKR therein. Molecular biology of immunoregula
FACULTY / SCHOOL: School of Medicine - IMRIC
DEPARTMENT: Biochemistry and Molecular Biology
Selected Publications
intragenic regulation of socs3 isoforms (2019)|
Cell Communication and Signaling|
Read more
treatment with one dose of reltecimod is superior to two doses in mouse models of lethal infection (2019)|
International Journal of Peptide Research and Therapeutics|
Read more
control of mrna splicing by intragenic rna activators of stress signaling potential implications for human disease (2019)|
Frontiers in Genetics|
Read more
staphylococcal and streptococcal superantigens trigger b7 cd28 costimulatory receptor engagement to hyperinduce inflammatory cytokines (2019)|
Frontiers in Immunology|
Read more
control of mrna splicing by noncoding intragenic rna elements that evoke a cellular stress response (2018)|
The International Journal of Biochemistry & Cell Biology|
Read more
bacterial superantigen toxins cd28 and drug development (2018)|
Toxins|
Read more
ribosome cycle emerges from dna replication (2017)|
Nature Reviews Molecular Cell Biology|
Read more
an ancient pseudoknot in tnf α pre mrna activates pkr inducing eif2α phosphorylation that potently enhances splicing (2017)|
Cell Reports|
Read more
pkr activation and eif2α phosphorylation mediate human globin mrna splicing at spliceosome assembly (2017)|
Cell Research|
Read more
bacterial superantigen toxins induce a lethal cytokine storm by enhancing b7 2 cd28 costimulatory receptor engagement a critical immune checkpoint (2017)|
Receptors and clinical investigation|
Read more
Success Stories & related Product & PR

ATOX BIO INC.
Atox Bio is focused on the discovery and development of therapeutics for the treatment of infectious and autoimmune diseases mediated by excessive T-cell response. Having developed novel immunomodulators that reduce autoimmune response, as well...